Jiang Jian Xin, Yu Chao, Li Zhi Peng, Xiao Jie, Zhang Hao, Chen Mei Yuan, Sun Cheng Yi
Department of Biliary-Hepatic Surgery, Affiliated Hospital of Guiyang Medical College, Guiyang, Guizhou Province, China.
J Cancer Res Ther. 2016 Apr-Jun;12(2):981-9. doi: 10.4103/0973-1482.154081.
Early diagnosis of hepatocellular cancer (HCC) significantly helps improve patient survival. However, high specific and sensitive tests for screening patients with early stage of HCC are not yet available. Novel HCC biomarkers based on gene expression profiles of peripheral blood mononuclear cells (PBMCs) might change the situation. Recently, a three gene-based signature for the non-invasive detection of early HCC was reported.
To compare the differences in global gene expression profiles in PBMCs of healthy individuals and HCC patients, with a specific aim to uncover the significantly altered biological pathways and important hub genes.
Two groups of data were extracted from Affymetrix microarray expression dataset GSE49515. One group had 10 PBMCs samples from healthy control individuals, and the other had 10 PBMCs samples from patients with HCC. Gene expression profiles of both groups were analyzed and compared. Furthermore, ribonucleic acid (RNA) levels of seven of the identified differentially expressed genes (DEGs) were further confirmed by quantitative reverse transcription polymerase chain reaction (QRT-PCR).
Significant differences were uncovered in gene expression profiles in PBMCs of healthy individuals and HCC patients. Three hundred and seventy-five up-regulated and 169 down-regulated DEGs were identified. Three hundred and eighty-seven gene ontology (GO) biological processes and 15 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were over-represented by the identified DEGs.
Using identified DEGs, significantly changed biological processes such as nucleic acid metabolic process and KEGG pathways such as cytokine-cytokine receptor interaction in PBMCs of HCC patients were identified. In addition, several important hub genes, for example, CUL4A, and interleukin (IL) 8 were also uncovered.
肝细胞癌(HCC)的早期诊断对提高患者生存率有显著帮助。然而,目前尚无用于筛查早期HCC患者的高特异性和高敏感性检测方法。基于外周血单个核细胞(PBMCs)基因表达谱的新型HCC生物标志物可能会改变这一现状。最近,有报道称一种基于三个基因的特征可用于早期HCC的无创检测。
比较健康个体和HCC患者PBMCs中整体基因表达谱的差异,特别旨在揭示显著改变的生物学通路和重要的枢纽基因。
从Affymetrix微阵列表达数据集GSE49515中提取两组数据。一组有来自健康对照个体的10个PBMCs样本,另一组有来自HCC患者的10个PBMCs样本。对两组的基因表达谱进行分析和比较。此外,通过定量逆转录聚合酶链反应(QRT-PCR)进一步确认了7个已鉴定的差异表达基因(DEGs)的核糖核酸(RNA)水平。
在健康个体和HCC患者的PBMCs基因表达谱中发现了显著差异。共鉴定出375个上调的DEGs和169个下调的DEGs。已鉴定的DEGs在387个基因本体论(GO)生物学过程和15条京都基因与基因组百科全书(KEGG)通路中过度富集。
利用已鉴定的DEGs,确定了HCC患者PBMCs中显著改变的生物学过程,如核酸代谢过程,以及KEGG通路,如细胞因子-细胞因子受体相互作用。此外,还发现了几个重要的枢纽基因,例如CUL4A和白细胞介素(IL)8。